Physician profile
Carl L Britton
NPI 1164506572
$23,602.77
in general payments reported to CMS, 2019-2025
38 companies · $807 in 2025
The $807 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,824 · 2020: $7,823 · 2021: $1,474 · 2022: $3,024 · 2023: $1,348 · 2024: $1,303 · 2025: $807.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,263 · Education: $194.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,263.40 |
| Education | $193.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $17,074.97 | 2019-2025 | Myrbetriq, Xtandi |
| Boston Scientific Corporation | $982.51 | 2019-2025 | Ams 700, Spaceoar Vue System - 10ml, Spaceoar System |
| Janssen Biotech, INC. | $805.38 | 2019-2025 | Erleada, Carvykti, Rybrevant |
| Procept Biorobotics Corporation | $508.20 | 2020-2025 | Aquabeam System, Aquabeam Robotic System |
| Abbvie INC. | $484.82 | 2019-2025 | Botox, Lupron Depot |
| Axonics, INC. | $478.86 | 2021-2024 | Axonics, Bulkamid |
| Dendreon Pharmaceuticals LLC | $434.07 | 2021-2025 | Provenge |
| Bayer Healthcare Pharmaceuticals INC. | $405.39 | 2021-2025 | |
| Coloplast Corp | $293.64 | 2020-2022 | |
| Pfizer INC. | $291.76 | 2020-2025 | |
| Sumitomo Pharma America, INC. | $271.89 | 2023-2025 | Gemtesa |
| Teleflex LLC | $178.79 | 2022 | |
| Urogen Pharma, INC. | $147.96 | 2020-2024 | |
| Storz Medical America, INC. | $133.14 | 2023 | |
| Ferring Pharmaceuticals INC. | $124.57 | 2019-2025 | Adstiladrin |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carl Britton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.